RESPECT
contact information:
Lori Marshall or www.clinicaltrials.gov #NCT00465270
202.741.2318 < back to clinical trials list
The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the prevention of recurrent embolic stroke.
contact information:
Lori Marshall or www.clinicaltrials.gov #NCT00465270
202.741.2318 < back to clinical trials list
ABOUT SSL CERTIFICATES |